13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000950123-25-005465
Total Value
$675.9M
Positions
24
Other Managers
12
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,719,110 | $219.4M | 32.46% |
| 2 | NUVALENT INC | NUVL | 1,447,267 | $102.6M | 15.19% |
| 3 | PHARVARIS N V | PHVS | 3,303,381 | $51.9M | 7.67% |
| 4 | DISC MEDICINE INC | IRON | 983,500 | $48.8M | 7.22% |
| 5 | DIANTHUS THERAPEUTICS INC | DNTH | 2,689,707 | $48.8M | 7.22% |
| 6 | SAVARA INC | SVRA | 17,600,621 | $48.8M | 7.21% |
| 7 | SOLID BIOSCIENCES INC | SLDB | 7,911,669 | $29.3M | 4.33% |
| 8 | OLEMA PHARMACEUTICALS INC | OLMA | 6,843,954 | $25.7M | 3.81% |
| 9 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $22.3M | 3.29% |
| 10 | CIDARA THERAPEUTICS INC | 171757206 | 703,080 | $15.1M | 2.24% |
| 11 | UPSTREAM BIO INC | UPB | 2,295,322 | $14.0M | 2.08% |
| 12 | ANNEXON INC | ANNX | 5,249,069 | $10.1M | 1.50% |
| 13 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $7.4M | 1.10% |
| 14 | KYVERNA THERAPEUTICS INC | KYTX | 3,368,370 | $6.5M | 0.96% |
| 15 | X4 PHARMACEUTICALS INC | XFOR | 16,915,784 | $4.0M | 0.59% |
| 16 | CABALETTA BIO INC | CABA | 2,760,888 | $3.8M | 0.57% |
| 17 | TANGO THERAPEUTICS INC | TNGX | 2,712,008 | $3.7M | 0.55% |
| 18 | XILIO THERAPEUTICS INC | XLO | 4,566,817 | $3.3M | 0.49% |
| 19 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $3.0M | 0.44% |
| 20 | CENTURY THERAPEUTICS INC | IPSC | 5,410,361 | $2.6M | 0.38% |
| 21 | C4 THERAPEUTICS INC | CCCC | 1,111,910 | $1.8M | 0.26% |
| 22 | INVIVYD INC | IVVD | 1,799,595 | $1.1M | 0.16% |
| 23 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 1,072,421 | $923,354 | 0.14% |
| 24 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $899,000 | 0.13% |